Press Releases2015

Feb 02, 2015
Essel Propack - growth continues in Q3 FY15

Revenues up 5.7% at Rs. 567.4 crore; PAT rises to Rs. 30.4 crore, up 7.4%

Consolidated Results comparison: Q3FY15 vs. Q3FY14:

  • Income from Operations at Rs. 567.4 crore, up 5.7%
  • Net profit at Rs. 30.4 crore, up 7.4%
  • EBITDA margin at 16.2% as against 16.8%
  • EPS for the quarter ended December 31, 2014 was Rs.1.94 as against Rs. 1.80 on Rs. 2 face value per share
  • Non Oral Care Revenue growth at 15.2%

Consolidated Results comparison: Nine months ended Dec 14 FY15 vs. FY14:

  • Income from Operations at Rs. 1711.2 crore, up 10.9%
  • Net profit at Rs.95.2 crore, up 18.3%
  • EBITDA margin at 16.8% as against 17.2%
  • EPS for six months ended December 31, 2014 was Rs. 6.06 as against Rs. 5.13 on Rs. 2 face value per share

Essel Propack Limited (NSE: ESSELPACK, BSE: 500135), a global leader in laminated plastic tubes catering to the FMCG & Pharma space, announced its financial results for quarter and the nine months ended December 31, 2014.

For the quarter ended December 31 2014, the company's consolidated net profit was up 7.4% at Rs. 30.4 crore compared to Rs. 28.3 crore in the corresponding quarter of last year.

The consolidated revenue for the global operations during the quarter were up 5.7% at Rs. 567.4 crore, as against Rs. 536.8 crore in the corresponding quarter of the previous year. EBIDTA for the quarter stood at Rs. 92 crore up 2.2% compared to Rs. 89.9 crore in the year-ago quarter.

For the nine months period ended December 31, 2014, the company's consolidated revenue rose 10.9% to Rs. 1711.2 crore whereas the consolidated net profit was up at Rs. 95.2 crore as compared to Rs. 80.5 crore in nine months of FY14, an increase of 18.3%.  EBIDTA for nine months of FY15 rose 8.2% to Rs. 287.5 crore compared to Rs. 265.7 crore in the same period last fiscal.

Statement from Ashok Goel, Vice Chairman & Managing Director, Essel Propack Limited:

"Our strategy for growing the non-oral care business is on track and has shown positive results. During the quarter under review, our non-oral care business grew by 15.2 % over last year. However, the revenue was impacted by unusually lower off take in the oral care category during Q3FY15. In fact, Year to date revenue grew by 10.9% and PAT by 18.3%.

Business Highlights for the Quarter ended December 31, 2014:

  • Non oral care revenue for the quarter continued to grow strongly at 15.2% over previous year.
  • Americas and Europe revenue posted robust growth with improved operating margin.
  • EAP non oral care thrust is on plan, recording revenue growth of 41.9% during the quarter, albeit on a lower base.
  • The quarter revenue is mainly impacted by unusually lower off take by key oral care customers.

« Back